This comprehensive report provides a detailed analysis of the global kidney cancer or renal cancer market, projecting significant growth through 2032. The study examines key segments including targeted therapy, chemotherapy, and immunotherapy, while evaluating applications across hospitals and pharmacies. By analyzing regional trends in the Americas, APAC, and Europe, the research highlights market drivers and competitive landscapes involving major players like Novartis and Roche. Ultimately, the report offers strategic insights into market dynamics, product segmentation, and emerging opportunities.

Market Overview

The global Kidney Cancer or Renal Cancer market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate over the forecast period.

Kidney cancer, also known as renal cancer, refers to cancer that originates in the kidneys. The kidneys are two bean-shaped organs located on either side of the spine, responsible for filtering blood, removing waste, and producing urine. Kidney cancer can take several forms, but the most common type is renal cell carcinoma (RCC).

Regional Market Analysis

• United States: The market for Kidney Cancer or Renal Cancer in the United States is estimated to increase from 2025 through 2032, growing at a consistent compound annual growth rate.
• China: The market for Kidney Cancer or Renal Cancer in China is estimated to increase from 2025 through 2032, growing at a consistent compound annual growth rate.
• Europe: The market for Kidney Cancer or Renal Cancer in Europe is estimated to increase from 2025 through 2032, growing at a consistent compound annual growth rate.

Market Segmentation

By Type

• Targeted Therapy
• Chemotherapy
• Immunotherapy

By Application

• Hospital
• Pharmacy
• Other

By Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

Key Market Dynamics

In terms of revenue, the global two largest companies occupied a significant portion of the market share in 2025. This Insight Report provides a comprehensive analysis of the global Kidney Cancer or Renal Cancer landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

The report also analyses the strategies of leading global companies with a focus on Kidney Cancer or Renal Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Kidney Cancer or Renal Cancer market.

Key Players

The following companies have been profiled based on inputs gathered from primary experts and an analysis of the company's coverage, product portfolio, and market penetration:

• Novartis
• Gilead Sciences
• Roche
• Bristol-Myers Squibb
• Amgen
• AstraZeneca
• Merck & Co
• Takeda
• Merck KGaA
• Seagen
• Eli Lilly
• Pfizer
• GSK

Report Scope and Methodology

LPI (LP Information)' newest research report, the “Kidney Cancer or Renal Cancer Industry Forecast” looks at past sales and reviews total world Kidney Cancer or Renal Cancer sales in 2025, providing a comprehensive analysis by region and market sector of projected Kidney Cancer or Renal Cancer sales for 2026 through 2032. With Kidney Cancer or Renal Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Kidney Cancer or Renal Cancer industry.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Kidney Cancer or Renal Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Kidney Cancer or Renal Cancer. The report presents a comprehensive overview, market shares, and growth opportunities of the Kidney Cancer or Renal Cancer market by product type, application, key players and key regions and countries.

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Kidney Cancer or Renal Cancer Market Size (2021-2032)

    • 2.1.2 Kidney Cancer or Renal Cancer Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Kidney Cancer or Renal Cancer by Country/Region (2021, 2025 & 2032)

  • 2.2 Kidney Cancer or Renal Cancer Segment by Type

    • 2.2.1 Targeted Therapy

    • 2.2.2 Chemotherapy

    • 2.2.3 Immunotherapy

    • 2.2.4 Kidney Cancer or Renal Cancer Market Size by Type

      • 2.2.4.1 Kidney Cancer or Renal Cancer Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.4.2 Global Kidney Cancer or Renal Cancer Market Size Market Share by Type (2021-2026)

  • 2.3 Kidney Cancer or Renal Cancer Segment by Application

    • 2.3.1 Hospital

    • 2.3.2 Pharmacy

    • 2.3.3 Other

    • 2.3.4 Kidney Cancer or Renal Cancer Market Size by Application

      • 2.3.4.1 Kidney Cancer or Renal Cancer Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.4.2 Global Kidney Cancer or Renal Cancer Market Size Market Share by Application (2021-2026)

• 3 Kidney Cancer or Renal Cancer Market Size by Player

  • 3.1 Kidney Cancer or Renal Cancer Market Size Market Share by Player

    • 3.1.1 Global Kidney Cancer or Renal Cancer Revenue by Player (2021-2026)

    • 3.1.2 Global Kidney Cancer or Renal Cancer Revenue Market Share by Player (2021-2026)

  • 3.2 Global Kidney Cancer or Renal Cancer Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Kidney Cancer or Renal Cancer by Region

  • 4.1 Kidney Cancer or Renal Cancer Market Size by Region (2021-2026)

  • 4.2 Global Kidney Cancer or Renal Cancer Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Kidney Cancer or Renal Cancer Market Size Growth (2021-2026)

  • 4.4 APAC Kidney Cancer or Renal Cancer Market Size Growth (2021-2026)

  • 4.5 Europe Kidney Cancer or Renal Cancer Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Kidney Cancer or Renal Cancer Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Kidney Cancer or Renal Cancer Market Size by Country (2021-2026)

  • 5.2 Americas Kidney Cancer or Renal Cancer Market Size by Type (2021-2026)

  • 5.3 Americas Kidney Cancer or Renal Cancer Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Kidney Cancer or Renal Cancer Market Size by Region (2021-2026)

  • 6.2 APAC Kidney Cancer or Renal Cancer Market Size by Type (2021-2026)

  • 6.3 APAC Kidney Cancer or Renal Cancer Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Kidney Cancer or Renal Cancer Market Size by Country (2021-2026)

  • 7.2 Europe Kidney Cancer or Renal Cancer Market Size by Type (2021-2026)

  • 7.3 Europe Kidney Cancer or Renal Cancer Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Kidney Cancer or Renal Cancer by Region (2021-2026)

  • 8.2 Middle East & Africa Kidney Cancer or Renal Cancer Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Kidney Cancer or Renal Cancer Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Kidney Cancer or Renal Cancer Market Forecast

  • 10.1 Global Kidney Cancer or Renal Cancer Forecast by Region (2027-2032)

    • 10.1.1 Global Kidney Cancer or Renal Cancer Forecast by Region (2027-2032)

    • 10.1.2 Americas Kidney Cancer or Renal Cancer Forecast

    • 10.1.3 APAC Kidney Cancer or Renal Cancer Forecast

    • 10.1.4 Europe Kidney Cancer or Renal Cancer Forecast

    • 10.1.5 Middle East & Africa Kidney Cancer or Renal Cancer Forecast

  • 10.2 Americas Kidney Cancer or Renal Cancer Forecast by Country (2027-2032)

    • 10.2.1 United States Market Kidney Cancer or Renal Cancer Forecast

    • 10.2.2 Canada Market Kidney Cancer or Renal Cancer Forecast

    • 10.2.3 Mexico Market Kidney Cancer or Renal Cancer Forecast

    • 10.2.4 Brazil Market Kidney Cancer or Renal Cancer Forecast

  • 10.3 APAC Kidney Cancer or Renal Cancer Forecast by Region (2027-2032)

    • 10.3.1 China Kidney Cancer or Renal Cancer Market Forecast

    • 10.3.2 Japan Market Kidney Cancer or Renal Cancer Forecast

    • 10.3.3 Korea Market Kidney Cancer or Renal Cancer Forecast

    • 10.3.4 Southeast Asia Market Kidney Cancer or Renal Cancer Forecast

    • 10.3.5 India Market Kidney Cancer or Renal Cancer Forecast

    • 10.3.6 Australia Market Kidney Cancer or Renal Cancer Forecast

  • 10.4 Europe Kidney Cancer or Renal Cancer Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Kidney Cancer or Renal Cancer Forecast

    • 10.4.2 France Market Kidney Cancer or Renal Cancer Forecast

    • 10.4.3 UK Market Kidney Cancer or Renal Cancer Forecast

    • 10.4.4 Italy Market Kidney Cancer or Renal Cancer Forecast

    • 10.4.5 Russia Market Kidney Cancer or Renal Cancer Forecast

  • 10.5 Middle East & Africa Kidney Cancer or Renal Cancer Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Kidney Cancer or Renal Cancer Forecast

    • 10.5.2 South Africa Market Kidney Cancer or Renal Cancer Forecast

    • 10.5.3 Israel Market Kidney Cancer or Renal Cancer Forecast

    • 10.5.4 Turkey Market Kidney Cancer or Renal Cancer Forecast

  • 10.6 Global Kidney Cancer or Renal Cancer Forecast by Type (2027-2032)

  • 10.7 Global Kidney Cancer or Renal Cancer Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Kidney Cancer or Renal Cancer Forecast

• 11 Key Players Analysis

  • 11.1 Novartis

    • 11.1.1 Novartis Company Information

    • 11.1.2 Novartis Kidney Cancer or Renal Cancer Product Offered

    • 11.1.3 Novartis Kidney Cancer or Renal Cancer Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 Novartis Main Business Overview

    • 11.1.5 Novartis Latest Developments

  • 11.2 Gilead Sciences

    • 11.2.1 Gilead Sciences Company Information

    • 11.2.2 Gilead Sciences Kidney Cancer or Renal Cancer Product Offered

    • 11.2.3 Gilead Sciences Kidney Cancer or Renal Cancer Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Gilead Sciences Main Business Overview

    • 11.2.5 Gilead Sciences Latest Developments

  • 11.3 Roche

    • 11.3.1 Roche Company Information

    • 11.3.2 Roche Kidney Cancer or Renal Cancer Product Offered

    • 11.3.3 Roche Kidney Cancer or Renal Cancer Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Roche Main Business Overview

    • 11.3.5 Roche Latest Developments

  • 11.4 Bristol-Myers Squibb

    • 11.4.1 Bristol-Myers Squibb Company Information

    • 11.4.2 Bristol-Myers Squibb Kidney Cancer or Renal Cancer Product Offered

    • 11.4.3 Bristol-Myers Squibb Kidney Cancer or Renal Cancer Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Bristol-Myers Squibb Main Business Overview

    • 11.4.5 Bristol-Myers Squibb Latest Developments

  • 11.5 Amgen

    • 11.5.1 Amgen Company Information

    • 11.5.2 Amgen Kidney Cancer or Renal Cancer Product Offered

    • 11.5.3 Amgen Kidney Cancer or Renal Cancer Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 Amgen Main Business Overview

    • 11.5.5 Amgen Latest Developments

  • 11.6 AstraZeneca

    • 11.6.1 AstraZeneca Company Information

    • 11.6.2 AstraZeneca Kidney Cancer or Renal Cancer Product Offered

    • 11.6.3 AstraZeneca Kidney Cancer or Renal Cancer Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 AstraZeneca Main Business Overview

    • 11.6.5 AstraZeneca Latest Developments

  • 11.7 Merck & Co

    • 11.7.1 Merck & Co Company Information

    • 11.7.2 Merck & Co Kidney Cancer or Renal Cancer Product Offered

    • 11.7.3 Merck & Co Kidney Cancer or Renal Cancer Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Merck & Co Main Business Overview

    • 11.7.5 Merck & Co Latest Developments

  • 11.8 Takeda

    • 11.8.1 Takeda Company Information

    • 11.8.2 Takeda Kidney Cancer or Renal Cancer Product Offered

    • 11.8.3 Takeda Kidney Cancer or Renal Cancer Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Takeda Main Business Overview

    • 11.8.5 Takeda Latest Developments

  • 11.9 Merck KGaA

    • 11.9.1 Merck KGaA Company Information

    • 11.9.2 Merck KGaA Kidney Cancer or Renal Cancer Product Offered

    • 11.9.3 Merck KGaA Kidney Cancer or Renal Cancer Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 Merck KGaA Main Business Overview

    • 11.9.5 Merck KGaA Latest Developments

  • 11.10 Seagen

    • 11.10.1 Seagen Company Information

    • 11.10.2 Seagen Kidney Cancer or Renal Cancer Product Offered

    • 11.10.3 Seagen Kidney Cancer or Renal Cancer Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Seagen Main Business Overview

    • 11.10.5 Seagen Latest Developments

  • 11.11 Eli Lilly

    • 11.11.1 Eli Lilly Company Information

    • 11.11.2 Eli Lilly Kidney Cancer or Renal Cancer Product Offered

    • 11.11.3 Eli Lilly Kidney Cancer or Renal Cancer Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 Eli Lilly Main Business Overview

    • 11.11.5 Eli Lilly Latest Developments

  • 11.12 Pfizer

    • 11.12.1 Pfizer Company Information

    • 11.12.2 Pfizer Kidney Cancer or Renal Cancer Product Offered

    • 11.12.3 Pfizer Kidney Cancer or Renal Cancer Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 Pfizer Main Business Overview

    • 11.12.5 Pfizer Latest Developments

  • 11.13 GSK

    • 11.13.1 GSK Company Information

    • 11.13.2 GSK Kidney Cancer or Renal Cancer Product Offered

    • 11.13.3 GSK Kidney Cancer or Renal Cancer Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 GSK Main Business Overview

    • 11.13.5 GSK Latest Developments

• 12 Research Findings and Conclusion